Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
Antitumor activity observed with confirmed partial responses in 50% of patientsat highest…
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
Company AnnouncementCOPENHAGEN, Denmark; March 12, 2025 – Genmab A/S (Nasdaq: GMAB) Following…
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical…
Intuitive Machines Announces Completion of Redemption of its Outstanding Warrants
HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR)…
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025 16:30 ET | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO,…
zSpace Announces Date Change for its Conference Call to Discuss Fourth Quarter and Full Year 2024 Results
March 07, 2025 16:05 ET | Source: zSpace, Inc. SAN JOSE, Calif.,…
ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND ANNOUNCES UPSIZE
For Immediate Release – Not for Dissemination in the United States or…
LeddarTech Enters Into Amendments to Credit Facilityand Bridge Financing Offer
QUEBEC CITY, Canada, March 07, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc.…
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
March 05, 2025 17:52 ET | Source: Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass.,…